Literature DB >> 21440534

Rapid and reliable β-globin gene cluster haplotyping of sickle cell disease patients by FRET Light Cycler and HRM assays.

Philippe Joly1, Philippe Lacan, Caroline Garcia, Angelique Delasaux, Alain Francina.   

Abstract

BACKGROUND: β-Globin haplotypes are important to predict the clinical development of patients suffering from sickle cell disease (SCD). Five main haplotypes (Benin, Bantu, Senegal, Cameroon and Arabic-Indian) are defined for β(S) chromosomes and their determination usually requires the genotyping by restriction fragment length polymorphism (RFLP) of six to eight single nucleotide polymorphisms (SNPs). However, RFLP is time-consuming and can lead to a misdiagnosis in case of a supplementary SNP on the restriction sequence. We propose a rapid β-globin haplotyping method using fluorescence resonance transfer (FRET) and high resolution melting (HRM) assays.
METHODS: We have settled a fluorescence resonance energy transfer (FRET) assay for HincII ε, XmnI, HindIII (G)γ, HindIII (A)γ, HincII δ and a high resolution melting (HRM) assay for HincII ψβ. These six SNPs are sufficient in most cases to determine the β(S) haplotype.
RESULTS: Our methodology allowed us to successfully determine the β-globin haplotypes of 139 patients suffering from sickle cell disease. For some β(S) / β(0)-patients, a supplementary SNP has been identified on the HindIII (G)γ restriction sequence leading to a false-negative RFLP result.
CONCLUSION: Combination of FRET and HRM assays is a rapid and reliable method for the β-globin gene cluster haplotyping.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21440534     DOI: 10.1016/j.cca.2011.03.025

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  8 in total

1.  HBB loss of heterozygosity in the hemopoietic lineage gives rise to an unusual sickle-cell trait phenotype.

Authors:  Philippe Joly; Caroline Schluth-Bolard; Philippe Lacan; Claire Barro; Serge Pissard; Audrey Labalme; Damien Sanlaville; Catherine Badens
Journal:  Haematologica       Date:  2012-10-12       Impact factor: 9.941

Review 2.  Genetic Modifiers of Fetal Haemoglobin in Sickle Cell Disease.

Authors:  Stephan Menzel; Swee Lay Thein
Journal:  Mol Diagn Ther       Date:  2019-04       Impact factor: 4.074

3.  High level of heterozygous haplotype of hemoglobin in Abidjan population with mild malaria.

Authors:  Tosséa A Stéphane Koui; Alloh Albert Gnondjui; Adji Eric Gbessi; Ako Aristide Bérenger Ako; Baba Coulibaly; A Delpêche Aka; Bi Sery E Gonedele; Offiana André Toure; Ronan Jambou
Journal:  BMC Med Genomics       Date:  2022-05-23       Impact factor: 3.622

4.  High Resolution Melt (HRM) analysis is an efficient tool to genotype EMS mutants in complex crop genomes.

Authors:  Seosamh Ó Lochlainn; Stephen Amoah; Neil S Graham; Khalid Alamer; Juan J Rios; Smita Kurup; Andrew Stoute; John P Hammond; Lars Østergaard; Graham J King; Phillip J White; Martin R Broadley
Journal:  Plant Methods       Date:  2011-12-08       Impact factor: 4.993

5.  Development of a High-Resolution Melting Approach for Scanning Beta Globin Gene Point Mutations in the Greek and Other Mediterranean Populations.

Authors:  Christos Chassanidis; Effrossyni Boutou; Ersi Voskaridou; Angeliki Balassopoulou
Journal:  PLoS One       Date:  2016-06-28       Impact factor: 3.240

6.  A phased SNP-based classification of sickle cell anemia HBB haplotypes.

Authors:  Elmutaz M Shaikho; John J Farrell; Abdulrahman Alsultan; Hatem Qutub; Amein K Al-Ali; Maria Stella Figueiredo; David H K Chui; Lindsay A Farrer; George J Murphy; Gustavo Mostoslavsky; Paola Sebastiani; Martin H Steinberg
Journal:  BMC Genomics       Date:  2017-08-11       Impact factor: 3.969

7.  A Cross-Sectional Study of Detection of Beta Globin (HBB) Haplotypes Among Beta Thalassemia Patients.

Authors:  Ali Alsamiri; Fatma Alzahrani; Najlaa Filimban; Ammar Khojah; Raed Felimban; Talal Qadah
Journal:  Cureus       Date:  2021-02-16

8.  Diagnosis of Sickle Cell Disease and HBB Haplotyping in the Era of Personalized Medicine: Role of Next Generation Sequencing.

Authors:  Adekunle Adekile; Nagihan Akbulut-Jeradi; Rasha Al Khaldi; Maria Jinky Fernandez; Jalaja Sukumaran
Journal:  J Pers Med       Date:  2021-05-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.